Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Ribo-seq of human colorectal cancer cell line HCT116/L-OHP against HCT116


ABSTRACT: Oxaliplatin (L-OHP) serves as a standard chemotherapy for colorectal cancer, while the drug resistance is still a considerable challenge. Dysregulation of lncRNA is involved in cancer and recent translatomics has found some alleged lncRNA actually contained small open reading frames and could encode short peptides. This ribosome footprint profiling (Ribo-seq) was a paired-end sequencing and aimed to investigate whether lncRNA could regulate oxaliplatin resistance in colorectal cancer by encoding short peptides.

INSTRUMENT(S): unspecified

ORGANISM(S): Homo sapiens

SUBMITTER: Xinyi Wang 

PROVIDER: E-MTAB-10805 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2021-11-12 | E-MTAB-10806 | biostudies-arrayexpress
2019-10-29 | E-MTAB-7521 | biostudies-arrayexpress
2024-06-01 | E-MTAB-14084 | biostudies-arrayexpress
2016-01-19 | E-GEOD-67322 | biostudies-arrayexpress
2019-01-24 | PXD011144 | Pride
2012-11-27 | E-GEOD-42486 | biostudies-arrayexpress
2021-10-18 | E-MTAB-10886 | biostudies-arrayexpress
2023-08-31 | GSE119603 | GEO
2020-05-31 | GSE124808 | GEO
2018-05-06 | E-MTAB-5236 | biostudies-arrayexpress